Experimental study of the antithrombogenic behavior of Dacron vascular grafts coated with hydrophilic acrylic copolymers bearing salicylic acid residues.
The objective of the present work was study of the behavior of active coatings of hydrophilic acrylic polymers bearing salicylic acid residues linked covalently to the macromolecular chains, after their application to woven and knitted Dacron vascular grafts. In vitro tests were carried out under dynamic flow conditions using equipment especially designed to reproduce physiologic conditions, to determine the retention of the coating using a saline solution. Ex vivo tests were carried out in an extracorporeal circuit using the dog as an animal model. The study of the deposition of platelets was followed by labeling of autologous platelets with 111In-oxine, as well as by analysis of the surfaces of the prostheses by scanning electron microscopy. An application of thin coatings of hydrophilic acrylic copolymers improves the antithrombogenicity of the vascular grafts with respect to the uncoated prosthesis. The presence of relatively small amounts of units bearing salicylic acid residues in the copolymer chains (5-20 wt %) gives good results when they are applied to woven and knitten Dacron meshes which have been quantified by analysis of the percentage of radiotracer on the surface of the vascular grafts tested in ex vivo experiments. The salicylic acid residues are released slowly to the medium by hydrolysis of the reversible covalent bonds of this compound to the acrylic macromolecular chains, which provides an additional antiaggregating effect for platelets. The polymeric coating forms a thin active film which improves the antithrombogenic properties of the surface of woven or knitted Dacron vascular grafts in ex vivo experiments.
San Román
J
J
Instituto de Ciencia y Tecnología de Polimeros, CSIC, Juan de la Cierva 3, Madrid, Spain.
Buján
J
J
Bellón
J M
JM
Gallardo
A
A
Escudero
M C
MC
Jorge
E
E
de Haro
J
J
Alvarez
L
L
Castillo-Olivares
J L
JL
D000818:Animals; D001672:Biocompatible Materials; D001705:Bioprosthesis; D004285:Dogs; D011093:Polyethylene Terephthalates; D011108:Polymers; D012459:Salicylates; D020156:Salicylic Acid; D013927:Thrombosis / Q000517:prevention & control
D001672:Biocompatible Materials; D011093:Polyethylene Terephthalates; D011108:Polymers; D012459:Salicylates; D020156:Salicylic Acid